HIF1A and neoplasm: The intermediary metabolites of the glycolytic pathway supply precursors for the synthesis of glycine, serine, purines, pyrimidines, and phospholipids, necessitating HIF-1-regulated metabolic reprogramming for tumor cell growth and maintenance under stress [28].